The Dawn of Federal Oversight
On January 23, 2026, the American hemp industry reached a historic milestone with the introduction of the Hemp Enforcement, Modernization, and Protection (HEMP) Act of 2026 (H.R. 7212). Sponsored by Rep. Morgan Griffith (R-VA) and Rep. Marc Veasey (D-TX), this bipartisan legislation is designed to solve the "Regulatory Vacuum" that has plagued the industry since the 2018 Farm Bill. By explicitly directing the FDA to regulate hemp-derived products as dietary supplements and food additives, H.R. 7212 represents the most significant step toward federal stabilization in a decade.
The 3-Year "Safety Net"
The core of the HEMP Act is a mandatory rulemaking process. The bill gives the Health Secretary (under the oversight of the current administration) exactly three years to establish milligram limits for hemp-derived cannabinoids. In a move that provides immediate "Regulatory Certainty," the bill includes an automatic backstop: if the FDA fails to finalize rules within that window, federal law will automatically set limits of 5mg per serving and 30mg per package for intoxicating cannabinoids.
Unlocking Institutional Capital
For years, Tier-1 retailers and institutional investors have remained on the sidelines due to the FDA’s refusal to provide a clear pathway. At Low Gravity Hemp, we view H.R. 7212 as the "Green Light" the industry has been waiting for. This bill doesn't just regulate; it legitimizes. By establishing standards for labeling, facility registration, and third-party testing, it creates a market where "Professionalism" is the primary currency.
